Identification and Validation of programmed cell death-related biomarkers in Osteoarthritis and an Exploratory Pan-Cancer Analysis: SHARPIN as a Potential Biomarker

Jianfei Xu, Rongxuan Wang, Liang Ding, Yu Luo, Yisha Gong, Yuxiao Deng, Tingting Ren

Open source

DOI
10.1007/s10067-026-08320-7
Published
2026-08-12
Container
Clinical Rheumatology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10067-026-08320-7,
  title = {Identification and Validation of programmed cell death-related biomarkers in Osteoarthritis and an Exploratory Pan-Cancer Analysis: SHARPIN as a Potential Biomarker},
  author = {Jianfei Xu and Rongxuan Wang and Liang Ding and Yu Luo and Yisha Gong and Yuxiao Deng and Tingting Ren},
  year = {2026},
  journal = {Clinical Rheumatology},
  doi = {10.1007/s10067-026-08320-7},
  url = {https://doi.org/10.1007/s10067-026-08320-7}
}

RIS

TY  - JOUR
TI  - Identification and Validation of programmed cell death-related biomarkers in Osteoarthritis and an Exploratory Pan-Cancer Analysis: SHARPIN as a Potential Biomarker
AU  - Jianfei Xu
AU  - Rongxuan Wang
AU  - Liang Ding
AU  - Yu Luo
AU  - Yisha Gong
AU  - Yuxiao Deng
AU  - Tingting Ren
PY  - 2026
JO  - Clinical Rheumatology
DO  - 10.1007/s10067-026-08320-7
UR  - https://doi.org/10.1007/s10067-026-08320-7
ER  - 

APA

Xu, J., Wang, R., Ding, L., Luo, Y., Gong, Y., Deng, Y., & Ren, T. (2026). Identification and Validation of programmed cell death-related biomarkers in Osteoarthritis and an Exploratory Pan-Cancer Analysis: SHARPIN as a Potential Biomarker. Clinical Rheumatology. https://doi.org/10.1007/s10067-026-08320-7

Source records